Astrazeneca (AZN) Exchange Rate Effect (2009 - 2026)

Astrazeneca has reported Exchange Rate Effect for 18 years, with the latest figure at $9.0 million in Q2 2026.

• On a quarterly basis, Exchange Rate Effect fell 68.97% year-over-year to $9.0 million in Q2 2026; TTM through Jun 2026 was -$17.0 million, a 230.77% decrease from a year earlier, with the FY2025 full-year figure at $46.0 million, up 149.46% from the prior year.
• Exchange Rate Effect was $9.0 million for Q2 2026 at Astrazeneca, up from -$18.0 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $29.0 million in Q2 2025, with the low at -$61.0 million in Q4 2024.
• Average Exchange Rate Effect over 5 years is -$9.9 million, with a median of -$10.0 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 318.18% in 2024, then surged 583.33% in 2025.
• Over 5 years, Exchange Rate Effect stood at -$26.0 million in 2022, then slumped by 38.46% to -$36.0 million in 2023, then slumped by 69.44% to -$61.0 million in 2024, then soared by 106.56% to $4.0 million in 2025, then surged by 125.0% to $9.0 million in 2026.
• The last three Exchange Rate Effect figures came in at $9.0 million (Q2 2026), -$18.0 million (Q1 2026), and $4.0 million (Q4 2025), per Business Quant data.